z-logo
Premium
MRI of cardiac iron overload
Author(s) -
Chu Winnie C.W.,
Au Wing Y.,
Lam Wynnie W.M.
Publication year - 2012
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.23628
Subject(s) - hemosiderosis , siderosis , medicine , chelation therapy , transfusion therapy , deferoxamine , thalassemia , deferiprone , heart failure , endocrine system , deferasirox , intensive care medicine , complication , cardiology , blood transfusion , hormone
Transfusion therapy has greatly improved the survival of transfusion dependent thalassemia major (TM) patients; however, the resultant iron load damages tissues including the heart, liver and endocrine organs. Among these, heart complication still remains the leading cause of mortality. Myocardial iron deposition can occur independently of other solid organ involvement; conversely, the heart may be spared despite heavy siderosis in other tissues. Iron chelation treatment diminishes the risk of hemosiderosis; however, the chelation treatment has its own toxicities and might not be available to all patients due to costs. Close monitoring of individual organ iron concentration and function is thus important for optimization of individual patient care. This review outlines the importance and clinical significance of recently available MRI techniques for monitoring cardiac iron load. J. Magn. Reson. Imaging 2012;36:1052–1059. © 2012 Wiley Periodicals Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here